Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2025 Filed Nov 13, 2025 23:00 UTC |
Kiu Cu SengDirector · Chief Financial Officer
|
GrantCommon Stock | 200,000 | $1.40 | $280,000.00 |
DisclosureSEC source: 0001493152-25-022421 · ownership.xml · nonDerivative · entry 1 Kiu Cu Seng · CIK 0001891617 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 23:00 UTC |
Doris Wong Sing EeDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 300,178 | $1.40 | $420,249.20 |
DisclosureSEC source: 0001493152-25-022422 · ownership.xml · nonDerivative · entry 1 Doris Wong Sing Ee · CIK 0001892421 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,111,131 F1 · balance_after: As adjusted for 1-for-16 reverse stock split on May 12, 2025 and 1-for-15 reverse stock split on July 7, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Yap Kim Choy10% owner
|
OtherSeries C Common Stock Warrants · Derivative | 31,535 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001493152-25-020918 · ownership.xml · derivative · entry 5 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,535 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Yap Kim Choy10% owner
|
OtherSeries B Common Stock Warrants · Derivative | 218,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001493152-25-020918 · ownership.xml · derivative · entry 4 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 218,000 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Yap Kim Choy10% owner
|
OtherSeries A Common Stock Warrants · Derivative | 218,000 | $0.00 Strike: $7.65 | $0.00 |
DisclosureSEC source: 0001493152-25-020918 · ownership.xml · derivative · entry 3 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 218,000 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Yap Kim Choy10% owner
|
OtherCommon Stock | 467,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-020918 · ownership.xml · nonDerivative · entry 2 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,535 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Yap Kim Choy10% owner
|
SaleCommon Stock | 28,540 | $1.70 | $48,518.00 |
DisclosureSEC source: 0001493152-25-020918 · ownership.xml · nonDerivative · entry 1 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Kua Khai Loon10% owner
|
OtherSeries C Common Stock Warrants · Derivative | 31,535 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001493152-25-020919 · ownership.xml · derivative · entry 4 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,535 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Kua Khai Loon10% owner
|
OtherSeries B Common Stock Warrants · Derivative | 218,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001493152-25-020919 · ownership.xml · derivative · entry 3 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 218,000 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Kua Khai Loon10% owner
|
OtherSeries A Common Stock Warrants · Derivative | 218,000 | $0.00 Strike: $7.65 | $0.00 |
DisclosureSEC source: 0001493152-25-020919 · ownership.xml · derivative · entry 2 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 218,000 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Kua Khai Loon10% owner
|
OtherCommon Stock | 467,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-020919 · ownership.xml · nonDerivative · entry 1 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,535 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025. Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Ong Yee Lung10% owner
|
OtherSeries C Common Stock Warrants · Derivative | 31,535 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001493152-25-020917 · ownership.xml · derivative · entry 4 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,535 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025 Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Ong Yee Lung10% owner
|
OtherSeries B Common Stock Warrants · Derivative | 218,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001493152-25-020917 · ownership.xml · derivative · entry 3 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 218,000 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025 Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Ong Yee Lung10% owner
|
OtherSeries A Common Stock Warrants · Derivative | 218,000 | $0.00 Strike: $7.65 | $0.00 |
DisclosureSEC source: 0001493152-25-020917 · ownership.xml · derivative · entry 2 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 218,000 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025 Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 23:00 UTC |
Ong Yee Lung10% owner
|
OtherCommon Stock | 467,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-020917 · ownership.xml · nonDerivative · entry 1 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,535 F1 · kind: Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025 Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 23:00 UTC |
Yap Kim Choy10% owner
|
SaleCommon Stock | 112,260 | $1.81 | $202,853.82 |
DisclosureSEC source: 0001493152-25-020647 · ownership.xml · nonDerivative · entry 1 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 23:00 UTC |
Kua Khai Loon10% owner
|
SaleCommon Stock | 242,477 | $1.80 | $436,458.60 |
DisclosureSEC source: 0001493152-25-020645 · ownership.xml · nonDerivative · entry 1 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 23:00 UTC |
Ong Yee Lung10% owner
|
SaleCommon Stock | 248,814 | $1.80 | $447,865.20 |
DisclosureSEC source: 0001493152-25-020644 · ownership.xml · nonDerivative · entry 1 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| October 29, 2025 Filed Oct 31, 2025 22:00 UTC |
Yap Kim Choy10% owner
|
SaleCommon Stock | 110,749 | $1.83 | $203,113.67 |
DisclosureSEC source: 0001493152-25-020479 · ownership.xml · nonDerivative · entry 1 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,760 Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 22:00 UTC |
Yap Kim Choy10% owner
|
SaleCommon Stock | 13,111 | $1.83 | $23,966.91 |
DisclosureSEC source: 0001493152-25-020277 · ownership.xml · nonDerivative · entry 1 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,509 Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 22:00 UTC |
Yap Kim Choy10% owner
|
SaleCommon Stock | 120,250 | $2.12 | $254,689.50 |
DisclosureSEC source: 0001493152-25-020109 · ownership.xml · nonDerivative · entry 1 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,620 Read SEC document |
| October 24, 2025 Filed Oct 28, 2025 22:00 UTC |
Ong Yee Lung10% owner
|
SaleCommon Stock | 19,858 | $1.99 | $39,517.42 |
DisclosureSEC source: 0001493152-25-019929 · ownership.xml · nonDerivative · entry 1 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,814 Read SEC document |
| October 24, 2025 Filed Oct 28, 2025 22:00 UTC |
Yap Kim Choy10% owner
|
SaleCommon Stock | 19,595 | $1.90 | $37,269.69 |
DisclosureSEC source: 0001493152-25-019928 · ownership.xml · nonDerivative · entry 1 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,870 Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 22:00 UTC |
FITTERS Diversified Berhad10% owner
|
SaleCommon Stock | 92,352 | $3.01 | $277,517.76 |
DisclosureSEC source: 0001493152-25-019139 · ownership.xml · nonDerivative · entry 1 FITTERS Diversified Berhad · CIK 0002086215 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,248 Read SEC document |
| October 20, 2025 Filed Oct 22, 2025 22:00 UTC |
FITTERS Diversified Berhad10% owner
|
SaleCommon Stock | 108,107 | $3.09 | $333,834.42 |
DisclosureSEC source: 0001493152-25-018963 · ownership.xml · nonDerivative · entry 1 FITTERS Diversified Berhad · CIK 0002086215 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,600 Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 22:00 UTC |
Kua Khai Loon10% owner
|
SaleCommon Stock | 88,204 | $4.22 | $371,956.27 |
DisclosureSEC source: 0001493152-25-018694 · ownership.xml · nonDerivative · entry 2 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,477 Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 22:00 UTC |
FITTERS Diversified Berhad10% owner
|
SaleCommon Stock | 26,051 | $5.50 | $143,280.50 |
DisclosureSEC source: 0001493152-25-018693 · ownership.xml · nonDerivative · entry 1 FITTERS Diversified Berhad · CIK 0002086215 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479,707 Read SEC document |
| October 15, 2025 Filed Oct 20, 2025 22:00 UTC |
Kua Khai Loon10% owner
|
SaleCommon Stock | 7,479 | $5.66 | $42,338.62 |
DisclosureSEC source: 0001493152-25-018694 · ownership.xml · nonDerivative · entry 1 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,681 Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 22:00 UTC |
Ong Yee Lung10% owner
|
SaleCommon Stock | 135,793 | $6.00 | $814,758.00 |
DisclosureSEC source: 0001493152-25-018350 · ownership.xml · nonDerivative · entry 1 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,672 Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 22:00 UTC |
FITTERS Diversified Berhad10% owner
|
SaleCommon Stock | 51,400 | $5.26 | $270,261.20 |
DisclosureSEC source: 0001493152-25-018069 · ownership.xml · nonDerivative · entry 1 FITTERS Diversified Berhad · CIK 0002086215 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 505,758 Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 22:16 UTC |
FITTERS Diversified Berhad10% owner
|
SaleCommon Stock | 142,000 | $5.29 | $751,606.00 |
DisclosureSEC source: 0001493152-25-017830 · ownership.xml · nonDerivative · entry 1 FITTERS Diversified Berhad · CIK 0002086215 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 557,158 Read SEC document |
| September 16, 2025 Filed Oct 10, 2025 22:17 UTC |
Kua Khai Loon10% owner
|
SaleCommon Stock | 25,000 | $5.13 | $128,300.00 |
DisclosureSEC source: 0001493152-25-017832 · ownership.xml · nonDerivative · entry 2 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,160 Read SEC document |
| September 12, 2025 Filed Oct 10, 2025 22:17 UTC |
Kua Khai Loon10% owner
|
SaleCommon Stock | 22,251 | $6.22 | $138,490.22 |
DisclosureSEC source: 0001493152-25-017832 · ownership.xml · nonDerivative · entry 1 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,160 Read SEC document |
| September 05, 2025 Filed Sep 10, 2025 19:09 UTC |
Kua Khai Loon10% owner
|
SaleCommon Stock | 19,054 | $7.01 | $133,568.54 |
DisclosureSEC source: 0001493152-25-012981 · ownership.xml · nonDerivative · entry 1 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,411 Read SEC document |
| September 04, 2025 Filed Sep 4, 2025 20:00 UTC |
Yap Kim Choy10% owner
|
OtherSeries C Common Stock Warrants · Derivative | 186,465 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001641172-25-026573 · ownership.xml · derivative · entry 2 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,535 Underlying: Common Stock · 186,465 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025. Read SEC document |
| September 04, 2025 Filed Sep 4, 2025 20:00 UTC |
Yap Kim Choy10% owner
|
OtherCommon Stock | 186,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-026573 · ownership.xml · nonDerivative · entry 1 Yap Kim Choy · CIK 0002081554 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,465 F1 · kind: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025. F1 · price: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025. Read SEC document |
| September 04, 2025 Filed Sep 4, 2025 20:00 UTC |
Ong Yee Lung10% owner
|
OtherSeries C Common Stock Warrants · Derivative | 186,465 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001641172-25-026572 · ownership.xml · derivative · entry 2 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,535 Underlying: Common Stock · 186,465 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025. Read SEC document |
| September 04, 2025 Filed Sep 4, 2025 20:00 UTC |
Ong Yee Lung10% owner
|
OtherCommon Stock | 186,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-026572 · ownership.xml · nonDerivative · entry 1 Ong Yee Lung · CIK 0002081473 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,465 F1 · kind: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025. F1 · price: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025. Read SEC document |
| September 04, 2025 Filed Sep 4, 2025 20:00 UTC |
Kua Khai Loon10% owner
|
OtherSeries C Common Stock Warrants · Derivative | 186,465 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001641172-25-026574 · ownership.xml · derivative · entry 2 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,535 Underlying: Common Stock · 186,465 shares Expires 2030-06-20 F1 · kind: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement Read SEC document |
| September 04, 2025 Filed Sep 4, 2025 20:00 UTC |
Kua Khai Loon10% owner
|
OtherCommon Stock | 186,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001641172-25-026574 · ownership.xml · nonDerivative · entry 1 Kua Khai Loon · CIK 0002081556 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,465 F1 · kind: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement F1 · price: Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement Read SEC document |
| July 30, 2025 Filed Aug 4, 2025 23:23 UTC |
Lazar David E.10% owner
|
SaleCommon Stock | 6,750 | $12.36 | $83,430.00 |
DisclosureSEC source: 0000921895-25-002082 · form412227019_08042025.xml · nonDerivative · entry 1 Lazar David E. · CIK 0001932843 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,838 F1 · balance_after: The number Shares owned by the Reporting Person is reflective of a 1-for-15 reverse stock split effected by the Issuer on July 7, 2025 (the "Reverse Stock Split"). F2 · balance_after: Due to an inadvertent ministerial error, the Form 4 filed by the Reporting Person on February 28, 2025 reported beneficial ownership of 354,738 shares of the Issuer's Series D Convertible Preferred Stock which had already been converted into 162,588 shares of Common Stock (after giving effect to the Reverse Stock Split) as of such date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:48 UTC |
NATAN DAVIDDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 700,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0000921895-25-000652 · form412227019nat_02282025.xml · derivative · entry 1 NATAN DAVID · CIK 0001253108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2035-02-26 F1 · shares: On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date. F2 · shares: Includes shares of Common Stock previously reported in Table I of the Reporting Person's Form 4 filed on January 7, 2025, which were not issued by the Company and are being replaced with the option grant reported in this Form 4. F1 · price: On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date. F1 · derivative.exercise_date: On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:47 UTC |
Ben-Tzvi AvrahamDirector
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 700,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0000921895-25-000650 · form412227019ben_02282025.xml · derivative · entry 1 Ben-Tzvi Avraham · CIK 0001944721 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2035-02-26 F1 · price: On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date. F1 · derivative.exercise_date: On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:48 UTC |
Lazar David E.Interim CEO · 10% owner
|
Exercise / conversionSeries D Convertible Preferred Stock · Derivative | 1,745,262 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-25-000651 · form412227019laz_02282025.xml · derivative · entry 5 Lazar David E. · CIK 0001932843 · Interim CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,738 Underlying: Common Stock · 191,978,820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The shares of Series D Preferred Stock are convertible at the option of the Reporting Person for no additional consideration. F9 · price: At a closing on February 6, 2025, the Reporting Person acquired 2,100,000 shares of Series D Preferred Stock from the Company for a total purchase price of $2,100,000. Each share of Series D Preferred Stock is convertible into 110 shares of the Company's Common Stock at any time. F8 · derivative.exercise_date: The Series D Preferred Stock is exercisable immediately upon issuance, is perpetual and has no expiration date. F8 · derivative.expiration_date: The Series D Preferred Stock is exercisable immediately upon issuance, is perpetual and has no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:48 UTC |
Lazar David E.Interim CEO · 10% owner
|
Exercise / conversionSeries C Convertible Preferred Stock · Derivative | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-25-000651 · form412227019laz_02282025.xml · derivative · entry 4 Lazar David E. · CIK 0001932843 · Interim CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,650,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The shares of Series C Preferred Stock are convertible at the option of the Reporting Person for no additional consideration. F7 · price: At a closing on January 6, 2025, the Reporting Person acquired 1,000,000 shares of Series C Preferred Stock from the Company for a total purchase price of $1,000,000. Each share of Series C Preferred Stock is convertible into 2.65 shares of the Company's Common Stock at any time. F6 · derivative.exercise_date: The Series C Preferred Stock is exercisable immediately upon issuance, is perpetual and has no expiration date. F6 · derivative.expiration_date: The Series C Preferred Stock is exercisable immediately upon issuance, is perpetual and has no expiration date. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:48 UTC |
Lazar David E.Interim CEO · 10% owner
|
SaleCommon Stock | 194,628,820 | $0.03 | $5,507,995.61 |
DisclosureSEC source: 0000921895-25-000651 · form412227019laz_02282025.xml · nonDerivative · entry 3 Lazar David E. · CIK 0001932843 · Interim CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F5 · shares: On February 26, 2025, the Reporting Person sold 194,628,820 shares of Common Stock in a private transaction for total consideration of $5,500,000. F5 · price: On February 26, 2025, the Reporting Person sold 194,628,820 shares of Common Stock in a private transaction for total consideration of $5,500,000. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:48 UTC |
Lazar David E.Interim CEO · 10% owner
|
Exercise / conversionCommon Stock | 191,978,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-25-000651 · form412227019laz_02282025.xml · nonDerivative · entry 2 Lazar David E. · CIK 0001932843 · Interim CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,628,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These shares represent the conversion of 1,745,262 shares of the Company's Series D Convertible Preferred Stock (the "Series D Preferred Stock") owned by the Reporting Person into shares of Common Stock of the Company. F4 · price: The shares of Series D Preferred Stock are convertible at the option of the Reporting Person for no additional consideration. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:48 UTC |
Lazar David E.Interim CEO · 10% owner
|
Exercise / conversionCommon Stock | 2,650,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-25-000651 · form412227019laz_02282025.xml · nonDerivative · entry 1 Lazar David E. · CIK 0001932843 · Interim CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,650,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares represent the conversion of 1,000,000 shares of the Series C Convertible Preferred Stock (the "Series C Preferred Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") owned by the Reporting Person into shares of the Company's common stock, par value $0.001 per share (the "Common Stock"). F2 · price: The shares of Series C Preferred Stock are convertible at the option of the Reporting Person for no additional consideration. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 22:45 UTC |
Lazar David E.Interim CEO · 10% owner
|
GrantSeries D Convertible Preferred Stock · Derivative | 2,100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-25-000312 · form412227001cycc_02102025.xml · derivative · entry 2 Lazar David E. · CIK 0001932843 · Interim CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100,000 Underlying: Common Stock · 231,000,000 shares Expires not disclosed F4 · security: At a closing on February 6, 2025, the Reporting Person acquired 2,100,000 shares of Series D Preferred Stock for a total purchase price of $2,100,000. Each share of Series D Preferred Stock is convertible into 110 shares of the Company's Common Stock at any time. F5 · derivative.exercise_price: The shares of Series D Preferred Stock are convertible at the option of the Reporting Person for no additional consideration. F4 · date: At a closing on February 6, 2025, the Reporting Person acquired 2,100,000 shares of Series D Preferred Stock for a total purchase price of $2,100,000. Each share of Series D Preferred Stock is convertible into 110 shares of the Company's Common Stock at any time. F4 · price: At a closing on February 6, 2025, the Reporting Person acquired 2,100,000 shares of Series D Preferred Stock for a total purchase price of $2,100,000. Each share of Series D Preferred Stock is convertible into 110 shares of the Company's Common Stock at any time. F6 · derivative.expiration_date: The Series D Preferred Stock is perpetual and therefore has no expiration date. Read SEC document |
| January 02, 2025 Filed Jan 8, 2025 00:07 UTC |
NATAN DAVIDDirector
|
GrantCommon Stock | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-25-000087 · form412227001_01072025.xml · nonDerivative · entry 1 NATAN DAVID · CIK 0001253108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · price: Shares of restricted stock issued pursuant to a Director Agreement dated as of January 2, 2025 by and between Cyclacel Pharmaceuticals, Inc. and David Natan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.